
Both vaccinations gives protection against COVID-19 variants. Medical experts have warned against comparing vaccines.
Ministry of Health and Family Welfare(MoHFW) affirms that "There is no head-to-head comparison done between the two vaccines being used in India." According to MoHFW, both Covaxin and Covidsheild are "work fine" to prevent infection and prevent a person from reaching the "severe state of the disease." Concerning the long-term effects, it would prevent deaths in "elderly people or those who have comorbidities."
Further, MoHFW stated that "all vaccines are expected to provide reasonable amount of protection against the mutated virus also." This is because a "body responds to vaccination by making more than one type of antibodies to virus parts including spike protein." They informed to date, the variants reported are "unlikely to make the vaccine ineffective," based on the available data.
The statement released on June 28, 2021, by MoHFW noted that Covaxin and Covidsheild are both "effective against the Alpha, Beta, Gamma and Delta variants." Vaccine effectiveness on Delta Plus Variant is ongoing.
Reports show that the efficacy of Covaxin is at a higher level than Covishield. However, the effectiveness of the community is in progress. Medical News Today explains, "Vaccine efficacy is the percentage reduction in a disease in a group of people who received a vaccination in a clinical trial," and the vaccination effectiveness refers to how well a vaccine performs in the real world, outside of clinical studies.
Therefore, all trials use different criteria for what counts as an infection which can lead to variations in results for effectiveness. However, all of the vaccines will reduce hospitalisations and deaths.
The COVID-19 pandemic has given rise to a lot of potentially dangerous misinformation. For reliable advice on COVID-19, including symptoms, prevention, and available treatment, please refer to the World Health Organization or your national healthcare authority.
Copied!